Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K
Cancer Vaccines01:30

Cancer Vaccines

347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Recent advances in oncolytic virotherapy: insights from clinical trials and combination treatment strategies.

Virology journal·2026
Same author

Different SARS-CoV-2 Subvariants and Coagulation Markers Trend: A Retrospective Multicentric Study From Iranian Network for Research in Viral Diseases (INRVD).

Health science reports·2026
Same author

Epidemiology and Clinical Outcomes of HTLV-1: A Comprehensive Narrative Review of Endemic and Nonendemic Regions.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale·2026
Same author

Assessment of Awareness and Knowledge Regarding Human T-Lymphotropic Virus Type 1 (HTLV-1) Among Healthcare Workers at Imam Khomeini Hospital Complex, Tehran, in 2023-2024, A Cross-Sectional Descriptive-Analytical Study.

Health science reports·2026
Same author

Unmasking HAM/TSP: understanding HTLV-1-driven neurological disease.

Journal of neurovirology·2026
Same author

Human betaretrovirus (HBRV), homologous to mouse mammary tumor virus (MMTV), and human breast cancer: a significant epidemiological association.

Retrovirology·2026

相关实验视频

Updated: Jun 17, 2025

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.6K

HTLV-1疫苗接种景观:当前的发展和挑战

Arash Letafati1,2, Mahshid Bahari2,3, Omid Salahi Ardekani2

  • 1Department of Virology, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Vaccine: X
|August 6, 2024
PubMed
概括

开发一种人类T淋巴细胞病毒1型 (HTLV-1) 疫苗对于对抗相关疾病至关重要. 研究探索各种疫苗平台,面临长期免疫力和病毒多样性的挑战.

关键词:
阿特尔公司 (ATLL)在HAM/TSPP上使用.在 HTLV-1 病毒中,疫苗接种 疫苗接种疫苗 疫苗 疫苗 疫苗

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

相关实验视频

Last Updated: Jun 17, 2025

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.6K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

科学领域:

  • 病毒学 病毒学
  • 免疫学 免疫学 免疫学
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 人类T淋巴细胞病毒1型 (HTLV-1) 在全球感染了5000万至1000万,与HAM/TSP和ATLL等严重疾病有关.
  • 此外,HTLV-1还会导致炎症性疾病,如脑膜炎和皮肤炎.
  • 需要有效的疫苗接种策略来减轻HTLV-1感染的全球负担.

研究的目的:

  • 审查目前人类T淋巴细胞病毒1型 (HTLV-1) 疫苗开发的进展情况.
  • 要突出正在研究的HTLV-1疫苗接种的多样化方法.
  • 确定在创建有效的HTLV-1疫苗方面面临的关键挑战和未来方向.

主要方法:

  • 关于HTLV-1疫苗研究的当前科学文献的综述.
  • 分析各种疫苗平台,包括病毒载体,DNA,蛋白质/,树突细胞和mRNA疫苗.
  • 针对性免疫反应的评估,如细胞毒性T淋巴细胞 (CTLs),辅助性T淋巴细胞 (HTLs) 和B细胞.

主要成果:

  • 目前正在研究多种疫苗策略,利用病毒成分引起免疫反应.
  • 在不同平台上观察到有希望的初步结果.
  • 仍然存在重大挑战,包括实现长期的保护性免疫力和解决病毒多样性.

结论:

  • 目前正在进行的研究表明,对HTLV-1疫苗的开发有希望,探索各种平台.
  • 克服与免疫持续时间和病毒变异性相关的挑战对于成功至关重要.
  • 持续监测进展对于有效打击HTLV-1相关疾病至关重要.